Académique Documents
Professionnel Documents
Culture Documents
Sepax
1800 345 6200 (Toll free) or +91 98301 66200 | www.cordlifeindia.com | info@Cordlifeindia.com
STEP
Cordlife
www.cordlifeindia.com | 1
2 | www.cordlifeindia.com
Platelets
Heart cells
Nerve cells
Liver cells
www.cordlifeindia.com | 3
Source
Peripheral Blood
Bone marrow
Cord Blood/
Cord Tissue
Collection
Multiple extractions
from donor invasive
operation under general
anesthesia.
Availability
Readily available
when needed.
Quality of
stem cells
Not as potent.
Lower risk of
complications
Matching is easier
Graft vs.
Host Disease
Matching
Issues
Cost
4 | www.cordlifeindia.com
www.cordlifeindia.com
www.cordlifeindia.com || 55
www.cordlifeindia.com | 5
The stem cells from the cord blood you store will be a perfect
match for your baby. It is also a ready source of genetically
related stem cells for someone else in the family. Compared
to bone marrow or other sources of the stem cells, the
likelihood* of locating a matching cord blood unit is 60%
higher between siblings.
100%
perfect match
for self
60%
Likelihood of locating
a matching cord
blood unit compared
to bone marrow
*Source: Based on 4 matches out of 6 human-leukocyte
antigen (HLA) markers
6 | www.cordlifeindia.com
www.cordlifeindia.com | 7
Sepax 2
Introducing India's first advanced automated processing technology Sepax 2. This Swiss made and FDA
Cleared device can recover as high as 99.46% Stem cells. This technology ensures 57% more cell count
higher than any other processing method.
Sepax 2 the future in stem cell processing technology:
Gives automated reading of the stem cells.
The yield from the cord blood processing is consistent, with high reproducible results
More cells are recovered / harvested from your baby's cord blood for future treatment (if needed), allowing
better chance of a successful transplant.
Complies with highest quality standards such as AABB and FACT-Netcord.
Over 75% public banks rely on Sepax 2 technology for processing.
Processes 2ml 220ml of Cord blood.
Takes only 25-35 minutes to complete the entire processing. Hence maintains maximum viability of the stem
cells.
Uses the cool mix technology to maintain the maximum viability of the stem cells.
8 | www.cordlifeindia.com
www.cordlifeindia.com | 9
Benifits to you
We process your babys cord blood
with high Swiss precision, reliable,
state-of the- art technology.
The yield from cord blood processing is
consistent, with reproducible high results
(that is cell recoveries).
Cell Recovery
Able to achieve as high as 99%1Total Nucleated Cells (TNC) recovery rate
Safety
Closed processing system.
Each processing step is fully monitored and traceable throughout the procedure.
Possesses a troubleshooting system. Even in cases of power failure, all cord
blood units can be reprocessed without having errors.
The only cord blood processing technology that processes one cord blood unit at
a time.
Conducts automated kit test before the start of procedure and pressure test to
check for any leakage.
It optimizes the sedimentation parameter for each cord blood unit.
Regulatory Approvals
Cleared by U.S. FDA, approved by European Union (evidenced by CE Mark),
and Japan MHLW (Ministry of Health and Labor Welfare).
Complies with the highest quality standards such as AABB & FACT-Netcord3.
Statistics/Evidence
An advanced cord blood processing technology with proven transplant track
record.
Worlds most tested and proven automated system.
Over 1 million cord blood units3 have been processed by the Sepax System in
over 50 countries, this is almost half of the worldwide processing procedures for
cord blood inventory.
Trusted by majority of the worlds leading public and private cord blood banks.
The Sepax system has been chosen by over 75% of the Netcord organizations
that group the leading public cord blood banks around the world.
Our investment in advanced technology
First Bank
now
and in the future means you and
Cordlife is the only private
cord
blood
bank
in
India
to
offer
automated
cord
blood
your family will benefit from any future
processing with Sepax 2.
technology upgrade for the long-term
storage of your babys stem cells.
References
1.Cordlife umbilical cord blood processing data as at 30 April 2013
2.Valeri et al., Transfusion 1996;36:303-8
3. Biosafe, manufacturer of Sepax (figures accurate as of 31 March 2013)
10 | www.cordlifeindia.com
www.cordlifeindia.com | 11
01
02
03
04
05
06
07
08
09
10
12 | www.cordlifeindia.com
1 in every 200 people may need to use his or her stem cells in a lifetime.
Sources: http://www.cordlifeindia.com/cord-blood-banking/why-bank-cord-blood
www.cordlifeindia.com | 13
What is Umbilical
Cord Banking?
MESENCHYMAL
STEM CELL
EPITHELIAL
STEM CELL
Gastro-intestinal Tract
Eye (Corneal)
Liver (Hepatogenic)
Skin (Keratogenic)
Pancreatic (Pancreatogenic)
Fat (Adipogenic)
Bone (Osteogenic)
Muscles/Cardiac Muscles
Cartilage (Chondrogenic)
Brain & Neurons
(Dopaminergic &Neuro)
14 | www.cordlifeindia.com
www.cordlifeindia.com | 15
1
How is Umbilical Cord 3
Collected, Processed
and Stored?
5
16 | www.cordlifeindia.com
STEP1
STEP3
STEP5
STEP2
STEP4
STEP6
www.cordlifeindia.com | 17
Blood Cancers
Metabolic Disorders
Adrenoleukodystrophy
Gaucher's Disease
Hurler Syndrome
Krabbe Disease
Metachromatic leukodystrophy
Osteopetrosis
Wolman Disease
Solid Tumors
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Langerhans' Cell Histiocytosis
Neuroblastoma
Retinoblastoma
Banking cord blood does not guarantee that the cells will provide a cure or be applicable in every situation. Use will be ultimately determined by the treating physician.
18 | www.cordlifeindia.com
www.cordlifeindia.com | 19
Clinical Trials:
With the advancement of stem cell* research, the potential for future use of stem cell grows. Below is a list
of diseases currently under Clinical Trials. These are diseases for which stem cell treatments have shown
to be beneficial, but have yet to be implemented as a standard treatment. Some of these stem cell
transplants only slow down the progression of the diseases, but do not produce a cure. For other diseases,
the stem cell treatments may result a cure, but the optimum dosage and usage of the stem cells are still
under study.
For the latest information, please visit www.clinicaltrials.gov
Experimental Treatments
These are randomised controlled trials conducted in a scientific laboratory involving in-vitro (test tube or cell
culture) and in-vivo (animal) work.
The experimental trials are in place to assist and to decide whether they have scientific merit for further
development / progression to clinical trials.
Cartilage repair
Cerebral palsy
Crohn's disease
Diabetes Type 1
Ewing Sarcoma
Multiple Sclerosis
Myocardial Infarction
Rheumatoid Arthritis
Spinal cord injury
Alzheimer's Disease
Amyotrophic lateral sclerosis
Congenital hydrocephalus
Huntington's Disease
Liver cirrhosis
Parkinson's Disease
Stroke
Systemic Lupus Erythematosus
Traumatic Brain Injury
www.cordlifeindia.com | 21
Cordlife's Total
Stem Cell
Banking Solution.
22 | www.cordlifeindia.com
Service Type
Cord Blood
Umbilical Cord
Proven
Potential
Cancers such as
Leukaemia and
Lymphoma,
Blood disorders
such as
Thalassaemia,
Metabolic
diseases, immuno
deficiencies
Cordlife's Exclusive:
Epithelial stem cells (EpSCs)
Potential
Wound / Soft Tissue Repair:
Surface ulcers (diabetic ulcers
etc) Various type of burns other
tissue trauma
Organ Regeneration: Liver,
Pancreas, Gastrointestinal trace
healing
Eye: Replacement of cornea
www.cordlifeindia.com | 23
Sepax2
Sepax2 - India's first automated
processing technology that recovers
99.46% stem cells.
Quality Guarantee
Cordlife's
360 Degree Protection
for Your entire family .
Natural Calamity
Relief Program
Extensive protection in case of unforeseen
circumstances if your stem cells are
destroyed Cordlife shall provide US$
25,000.
Cordlife Cares
Program
Cashless medical assistance for your
family-Cordlife provides a financial
assistance of US$25,000 for your family for
a stem cell transplant.
Worldwide
Free Transport
Worldwide free transportfree
transportation of your stem cells around the
world.
24 | www.cordlifeindia.com
www.cordlifeindia.com | 25
Explant, Differentiation
& Culture
www.cordlifeindia.com | 27
CordSURE BIOCORD
CordSURE BIOCORD is a basic Cordlife service package where stem cells from your baby's cord blood and
the umbilical cord tissue are collected processed and stored in India.
CordSURE EXPLANT
CordSURE EXPLANT is an advanced service package which consists of both long-term storage of stem
cells from your baby's cord blood and umbilical cord tissue. Your baby's umbilical cord tissue will be
processed and validated by Global Cord Registry in Singapore using their Patented Explant Differentiation
Conditioning and Culture Media. This important step will ensure the maximum viability of up to 4 billion cells
per cell line.
Our Services
28 | www.cordlifeindia.com
www.cordlifeindia.com | 29
Cordlife Limited is a leading healthcare group of companies that provides a full suite of umbilical cord and
cord blood banking services to expectant parents for the collection, processing and cryopreservation of
cord blood and umbilical cord stem cells . The Group is dedicated to offering the highest possibility of
successful adult stem cell therapy to give hope and save lives. Listed on the Australian Securities
Exchange, Cordlife Limited is well established as the largest network of private stem cell banks across
Asia Pacific with state-of-the-art facilities in India, Indonesia and the Philippines as well as an affiliate
network that extends to Singapore, Hong Kong, and China.
Cordlife Limited
at a glance
30 | www.cordlifeindia.com
Cordlife India is a majority-owned subsidiary of Cordlife Limited, a company listed on the Australian
Securities Exchange. A winner of Technology Pioneer award conferred by the World Economic Forum,
Cordlife has accumulated more than 10 years of experience in stem cell processing and
cryopreservation.
Cordlife Limited owns and operates 3 state-of-the-art stem cell processing and cryopreservation facilities
in India, Indonesia and the Philippines along with an affiliate network extending to other full-fledged
facilities in Singapore, Hong Kong and Mainland China.
www.cordlifeindia.com | 31
Globally Accredited
and Recognized
AABB Accreditation
32 | www.cordlifeindia.com
34 | www.cordlifeindia.com
Confirmation of Assurance
Cordlife is the first and only company in India to introduce the novel and patented technology of isolating,
differentiating and expanding the two cell lines (EpSCs and MSCs) from the umbilical cord lining confirming
the viability and functionality of the stem cells.
www.cordlifeindia.com | 35
Advantages of
Cordlife's Processing
and storage methods
36 | www.cordlifeindia.com
Storing tissue sections of the umbilical cord is the safest and most reliable way to store all the stem cells
which can be derived from the amniotic membrane, Wharton's jelly, perivascular and peri-allantoic tissue,
which contain other potentially valuable stem cells yet to be identified, opening up more medical options for
your family in the future.
www.cordlifeindia.com | 37
33
38 | www.cordlifeindia.com
www.cordlifeindia.com | 39
Moinam was just 4 months old when he was found to be suffering from E-Beta thalassaemia, his parents went all over India
in search for a cure. But wherever they went they found onlydisappointment until they learned that stem cell transplant is the
only permanent cure. During this time young Moinam went through a hard time because of regular blood transfusions, high
dose medications and a deteriorating health. The parents opted for stem cell therapy and planned for a second baby so that
the cord blood stem cells of the newborn could be used to save young Moinam's life. During his baby sister Ahoma's birth
her stem cells were collected and stored with Cordlife so that it could be used for transplant. The cord blood stem cells along
with bone marrow stem cells of Ahoma were used for this unique treatment, first such case in India. Since transplant young
Moinam has been showing signs of recovery and is already a figure of inspiration for many such suffering from this disease.
Young Moinam has started showing promises of improvement; his hemoglobin level has considerably increased which proves the engraftment has taken
place. He needs to be careful for another 3 months to ensure that his body gets used to the environment and then he can go back to a normal life.
Successful Release of
Stem cells for
Transplant and
Cellular Therapy
Sou
rce H
stan
Time
s
, 7th
2011
09
grap
e Tele
: Th
ource
May
er 20
cemb
De
h, 3rd
40 | www.cordlifeindia.com
indu
004
, 1 July 2
its Times
he Stra
ource: T
Client Testimonials
Anindya Chatterjee
(lead vocalist Chandrabindoo band ,Kolkata )
42 | www.cordlifeindia.com
www.cordlifeindia.com | 43
44 | www.cordlifeindia.com
www.cordlifeindia.com | 45
New Born Screening a practice accepted across 52 countries to ensure a safe healthy
future for your child.
Japan. - > 99 %
U.K. - > 99 %
China -60 %
USA - 100%
INDIA
<1 %
S.A. ~ 40 %
S.E. Asia
95-99%
Australia
100%
Source:
Padila, Ann Acad Med Singapore 2008;37(Suppl 3):6-9
NHS , U.K, 2011 data http://www.labnews.co.uk/features/childs-play-newborn-screening-in-the-uk/
Borrajo, 2007, J Inherit Metab Dis, 30:466-481
Padilla et al, J Community Genet (2012) 3:3545
Some of the genetic disorders that can be detected at early stage and even prevented with
simple dietary measures
Asthma
Cancers
Cleft Palate
Diabetes
Heart Disease
Hyper tension
Obesity
Epilepsy
Speech Difficulties
Pigmental defect
Lethargy
Learning disabilities
Hypotonic
Hyperactivity / Aggression
46 | www.cordlifeindia.com
www.cordlifeindia.com | 47